CLINICAL RESEARCH: HEART TRANSPLANTATION
Selection of patients for heart transplantationin the current era of heart failure therapy
Javed Butler, MD, MPH, FACC* ||¶,*,
Ghazanfar Khadim, MD*,
Kimberly M. Paul, MD ,
Stacy F. Davis, MD*,
Marvin W. Kronenberg, MD*,
Don B. Chomsky, MD*¶,
Richard N. Pierson, III, MD# and
John R. Wilson, MD*
* Division of Cardiovascular Medicine, Department of Medicine, Nashville, TennesseeUSA
Center for Health Services Research, Nashville, TennesseeUSA
Center for Education and Research in Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Cardiology Division, Emory University, Atlanta, Georgia, USA
|| Geriatric Research, Education, and Clinical Center, Nashville, TennesseeUSA
¶ Medicine Service, Nashville Veterans Affairs Medical Center, Nashville, Tennessee, USA
# Department of Cardiothoracic Surgery, University of Maryland, Baltimore, Maryland, USA
Manuscript received June 3, 2003;
revised manuscript received August 23, 2003,
accepted August 26, 2003.
* Reprint requests and correspondence: Dr. Javed Butler, Cardiology Division, 383 PRB, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6300, USA. javed.butler{at}vanderbilt.edu
OBJECTIVES: We sought to assess the relationship between survival, peak exercise oxygen consumption (VO2), and heart failure survival score (HFSS) in the current era of heart failure (HF) therapy.
BACKGROUND: Based on predicted survival, HF patients with peak VO2 <14 ml/min/kg or medium- to high-risk HFSS are currently considered eligible for heart transplantation. However, these criteria were developed before the widespread use of beta-blockers, spironolactone, and defibrillatorsinterventions known to improve the survival of HF patients.
METHODS: Peak VO2 and HFSS were assessed in 320 patients followed from 1994 to 1997 (past era) and in 187 patients followed from 1999 to 2001 (current era). Outcomes were compared between these two groups of patients and those who underwent heart transplantation from 1993 to 2000.
RESULTS: Survival in the past era was 78% at one year and 67% at two years, as compared with 88% and 79%, respectively, in the current era (both p < 0.01). One-year event-free survival (without urgent transplantation or left ventricular assist device) was improved in the current era, regardless of initial peak VO2: 64% vs. 48% for peak VO2 <10 ml/min/kg (p = 0.09), 81% vs. 70% for 10 to 14 ml/min/kg (p = 0.05), and 93% vs. 82% for >14 ml/min/kg (p = 0.04). Of the patients with peak VO2 of 10 to 14 ml/min/kg, 55% had low-risk HFSS and exhibited 88% one-year event-free survival. One-year survival after transplantation was 88%, which is similar to the 85% rate reported by the United Network for Organ Sharing for 1999 to 2000.
CONCLUSIONS: Survival for HF patients in the current era has improved significantly, necessitating re-evaluation of the listing criteria for heart transplantation.
|
Abbreviations and Acronyms
| | HF | = heart failure | | HFSS | = heart failure survival score | | LVAD | = left ventricular assist device | | UNOS | = United Network for Organ Sharing | | VO2 | = oxygen consumption |
|
This article has been cited by other articles:

|
 |

|
 |
 
T. P. Singh, L. A. Sleeper, S. Lipshultz, A. Cinar, C. Canter, S. A. Webber, D. Bernstein, E. Pahl, J. A. Alvarez, J. D. Wilkinson, et al.
Association of Left Ventricular Dilation at Listing for Heart Transplant With Postlisting and Early Posttransplant Mortality in Children With Dilated Cardiomyopathy
Circ Heart Fail,
November 1, 2009;
2(6):
591 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
e1 - e90.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, et al.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
1343 - 1382.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, et al.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation,
April 14, 2009;
119(14):
1977 - 2016.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation,
April 14, 2009;
119(14):
e391 - e479.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Hoercher, E. R. Nowicki, E. H. Blackstone, G. Singh, J. M. Alster, G. V. Gonzalez-Stawinski, R. C. Starling, J. B. Young, and N. G. Smedira
Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status 2 patients.
J. Thorac. Cardiovasc. Surg.,
May 1, 2008;
135(5):
1159 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Benzo, S. Paramesh, S. A. Patel, W. A. Slivka, and F. C. Sciurba
Optimal Protocol Selection for Cardiopulmonary Exercise Testing in Severe COPD
Chest,
November 1, 2007;
132(5):
1500 - 1505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Jankowska, T. Witkowski, B. Ponikowska, K. Reczuch, L. Borodulin-Nadzieja, S. D. Anker, M. F. Piepoli, W. Banasiak, and P. Ponikowski
Excessive ventilation during early phase of exercise: A new predictor of poor long-term outcome in patients with chronic heart failure
Eur J Heart Fail,
October 1, 2007;
9(10):
1024 - 1031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al.
Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation,
February 6, 2007;
115(5):
658 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L Clark
Exercise and heart failure: assessment and treatment.
Heart,
May 1, 2006;
92(5):
699 - 703.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
 |
|
|